Victrex PLC (LSE:VCT) shares jumped 9% to 680p, topping the FTSE 250, after the company’s full-year results and guidance reassured investors.
The update delivered no negative surprises, showed earnings broadly in line with expectations and set out a clearer plan to improve profitability, all of which helped steady market nerves after a patchy year for industrial names.
Volumes were the standout, rising 12% to 4,164 tonnes, driven by stronger demand from value-added resellers and the energy and industrial sectors.
Revenue held firm at £292.7 million, although the average selling price slipped to £70/kg, mainly because of mix effects and currency movements. Medical remained soft, with a 5% decline in spine-related sales, though non-spine products grew 7%.
Underlying profit before tax fell 21% to £46.4 million, reflecting an £8 million FX drag, start-up losses at the new China plant and a weaker mix. Gross margin dipped to 45.3%, but cash conversion improved and net debt stayed modest at £24.8 million.
Crucially, management launched a Profit Improvement Plan targeting at least £10 million in annual savings by FY27 and reaffirmed its dividend policy.
Guidance for the current year, low-to-mid single-digit volume growth, stable pricing and a steady margin, was seen as sensible and achievable.
Peel Hunt said the results were “in line and reassuring”, noting improved cash generation, the cost-saving programme and a more disciplined capital framework.
The broker kept its 'buy' rating and 880p price target, arguing that the long-term PEEK polymer opportunity remains intact.
With investors relieved by the absence of fresh shocks and encouraged by a clearer plan to lift profitability, the shares rallied strongly on the day.